Reaction

Neonatal Respiratory Distress reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 856 reports · 22 co-occurring drugs

As of the last recalculation, Neonatal Respiratory Distress appears in 856 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is AMPICILLIN (PRR 57.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ampicillin1957.057.2
Ampicillin Sodium1957.057.2
Oxazepam3035.135.2
Magnesium Sulfate Heptahydrate1528.528.5
Magnesium Sulfate1528.428.5
Magnesium Sulfate In Water For1427.127.1
Labetalol1426.026.0
Tranexamic Acid924.924.9
Lithium Carbonate1623.323.3
Nicotine Polacrilex Mini1321.421.4
Nicotine Polarilex1321.421.4
Gentamicin1120.720.7
Entecavir918.918.9
Methimazole618.718.7
Sumatriptan Succinate1817.717.7
Misoprostol717.617.6
Progesterone1617.317.3
Buspirone Hydrochloride715.515.6
Remdesivir814.714.7
Insulin Glulisine614.414.5
Buprenorphine Hydrochloride, Naloxone Hydrochloride99.29.2
Buprenorphine308.18.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.